Hooper Holmes, Inc.  

(Public, NYSEMKT:HH)   Watch this stock  
Find more results for Holmes´┐Ż
0.000 (0.04%)
Jan 30 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.46 - 0.49
52 week 0.44 - 0.83
Open 0.46
Vol / Avg. 51,307.00/71,905.00
Mkt cap 34.02M
P/E     -
Div/yield     -
EPS -0.10
Shares 70.87M
Beta 1.88
Inst. own 51%
Mar 30, 2015
Q4 2014 Hooper Holmes Inc Earnings Release (Estimated) Add to calendar
Nov 13, 2014
Q3 2014 Hooper Holmes Inc Earnings Call
Nov 13, 2014
Q3 2014 Hooper Holmes Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 0.98% -20.86%
Operating margin 1.82% -19.85%
EBITD margin - -13.29%
Return on average assets 1.72% -35.32%
Return on average equity 4.07% -55.19%
Employees 300 -
CDP Score - -


OLATHE, KS 66062
United States - Map
+1-913-7641045 (Phone)
+1-908-9536348 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Hooper Holmes, Inc. (Hooper Holmes) is engaged in providing health risk assessment services to the life insurance and health industries Hooper Holmes operates in one business segment and provides paramedical and medical examinations, personal health interviews and record collection, and laboratory testing, which help life insurance companies evaluate the risks associated with underwriting policies. It also conducts wellness screenings for wellness companies, disease management organizations and health plans. Its core activities consist of arranging for paramedical examinations on behalf of insurance carriers, primarily in connection with such carriers´┐Ż processing and evaluation of the risks associated with underwriting insurance policies - mainly life insurance policies. In September 2014, the Company announced the closing of transaction, under which Clinical Reference Laboratory, Inc has acquired certain assets comprising the businesses of Heritage Labs and Hooper Holmes Services.

Officers and directors

Ronald V. Aprahamian Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Henry E. Dubois President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Tom Collins Chief Financial Officer, Senior Vice President, Treasurer
Age: 37
Bio & Compensation  - Reuters
Tracy D. Mackey General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Larry R. Ferguson Independent Director
Age: 64
Bio & Compensation  - Reuters
Gus D. Halas Independent Director
Age: 63
Bio & Compensation  - Reuters
Thomas A. Watford Independent Director
Age: 53
Bio & Compensation  - Reuters